Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

GHK-Cu: Research & Evidence

Emerging Evidence

Published research, clinical trial data, and evidence grading for GHK-Cu across studied indications.

Back to GHK-Cu overview

Research Summary

GHK-Cu is one of the better-evidenced peptides with multiple human studies showing benefits for skin aging and wound healing. However, evidence is primarily 'cosmetic-grade' — small, often industry-funded studies using topical application. The copper-bound form is essential; GHK without copper has different properties.

Evidence by Indication (3 indications)

Indication Tier Trials Summary
Wound healing Tier C 3 Topical application accelerates wound closure in small trials
Skin aging / rejuvenation Tier C 4 Increases collagen synthesis and skin thickness in controlled studies
Hair loss Tier D 1 Preclinical evidence suggests follicle stimulation; human data limited

Graded using our evidence tier methodology.

Citations (5 sources)

  1. 1. Immunostimulatory Hydrogel with Synergistic Blockage of Glutamine Metabolism and Chemodynamic Therapy for Postoperative Management of Glioblastoma. Study

    (2025), Advanced science (Weinheim, Baden-Wurttemberg, Germany)

  2. 2. An Assessment of the Safety, Efficacy, and Tolerability of a Novel Scalp Treatment Regimen Combining a Hydroxy Acid-Based Scrub and Copper Tripeptide Serum in the Management of Seborrheic Dermatitis in Adults. Study

    (2024), Cureus

  3. 3. Microneedle-Mediated Delivery of Copper Peptide Through Skin. Study

    (2015), Pharmaceutical research

  4. 4. Using Aldara, copper peptide, and niacinamide for skin care. Study

    (2004), Aesthetic surgery journal

  5. 5. DNA- and protein-scission activities of ascorbate in the presence of copper ion and a copper-peptide complex. Study

    (1983), Journal of biochemistry